Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Margrit Carlson"'
Autor:
Karid Nieves-Borrero, Julie M Yabu, Ashrit Multani, Camille N. Kotton, Elizabeth Kendrick, Gabriel M. Danovitch, Basmah Abdalla, Suphamai Bunnapradist, Joanna Schaenman, Omer E. Beaird, Pryce Gaynor, Erik L. Lum, Phuong Chi T. Pham, Margrit Carlson
Publikováno v:
Transplantation Proceedings
Transplantation proceedings, vol 52, iss 9
Transplantation proceedings, vol 52, iss 9
Purpose We reviewed the clinical experience of kidney transplant recipients diagnosed with severe acute respiratory syndrome coronavirus 2 infection in order to understand the impact of the current coronavirus disease 2019 (COVID-19) pandemic infecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6cb146da7e5bd4839787d4fc7e4c983
https://doi.org/10.1016/j.transproceed.2020.09.005
https://doi.org/10.1016/j.transproceed.2020.09.005
Autor:
Marwah Shahid, Pryce Gaynor, Leigh Christopher Reardon, James Wilson, Margrit Carlson, Megan Y. Kamath
Publikováno v:
Journal of the American College of Cardiology. 79:2615
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::778fc217f0316781faefb3e9fb7d0e1b
https://doi.org/10.1016/s0735-1097(22)03606-3
https://doi.org/10.1016/s0735-1097(22)03606-3
Autor:
Omer E. Beaird, Ashrit Multani, Margrit Carlson, Pryce Gaynor, Matthew R Davis, Joanna Schaenman, Ali Nsair, Glen Huang, Mario C. Deng
Publikováno v:
Open Forum Infectious Diseases
Background Cytomegalovirus (CMV) is one of the most common infections after transplantation and continues to cause significant morbidity and mortality. Current guidelines recommend 3-6 months of post-transplant prophylaxis with 900mg daily of valganc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50277c229d9de34a4d99d9a480fcd7ff
https://doi.org/10.1093/ofid/ofaa439.1295
https://doi.org/10.1093/ofid/ofaa439.1295
Autor:
Hannah A. Sample, Michael R. Wilson, Jeffrey D. Klausner, Kara W. Chew, Steve Miller, Chelsea Shannon, Deepika Sirohi, Charles Y. Chiu, Jamie A. Murkey, Romney M. Humphries, Margrit Carlson, Paul M. Vespa
Publikováno v:
Open forum infectious diseases, vol 4, iss 3
Open Forum Infectious Diseases
Murkey, JA; Chew, KW; Carlson, M; Shannon, CL; Sirohi, D; Sample, HA; et al.(2017). Hepatitis E Virus-Associated Meningoencephalitis in a Lung Transplant Recipient Diagnosed by Clinical Metagenomic Sequencing. OPEN FORUM INFECTIOUS DISEASES, 4(3), ofx121. doi: 10.1093/ofid/ofx121. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/01t1g1mv
Open Forum Infectious Diseases
Murkey, JA; Chew, KW; Carlson, M; Shannon, CL; Sirohi, D; Sample, HA; et al.(2017). Hepatitis E Virus-Associated Meningoencephalitis in a Lung Transplant Recipient Diagnosed by Clinical Metagenomic Sequencing. OPEN FORUM INFECTIOUS DISEASES, 4(3), ofx121. doi: 10.1093/ofid/ofx121. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/01t1g1mv
Hepatitis E virus (HEV) infection uncommonly causes chronic hepatitis and neurologic disease. We describe a case of genotype 3a HEV meningoencephalitis diagnosed by metagenomic next-generation sequencing, illustrating the power of an unbiased molecul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e39b87efbd3288ad36c290d5b66d8b03
https://escholarship.org/uc/item/01t1g1mv
https://escholarship.org/uc/item/01t1g1mv
Autor:
Theodoros Kelesidis, Jordan E. Lake, Christopher Tymchuk, Margrit Carlson, Bernard M. Kubak, Joanna Schaenman, Jonathan Baghdadi
Publikováno v:
Open Forum Infectious Diseases. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a20543a82bdd599ef0a5e855dea747c8
https://doi.org/10.1093/ofid/ofv133.929
https://doi.org/10.1093/ofid/ofv133.929
Autor:
Fred T. Valentine, Sharon A. Riddler, Frances F. Haas, Donald W. Northfelt, David Henry, John Delehanty, Gary Richmond, Edwin DeJesus, Richard Haubrich, Prakash R. Sista, Ralph DeMasi, William G. Powderly, Melanie A. Thompson, David Wright, Miklos Salgo, Stephen Becker, Margrit Carlson, Peter R. Wolfe, Jacob Lalezari
Publikováno v:
Antiviral Therapy. 8:279-287
Enfuvirtide is a novel antiretroviral that blocks HIV-1 cell fusion and viral entry. This Phase II, controlled, open-label, randomized, multicentre dose-ranging trial explored the safety, antiviral activity and pharmacoki-netics of enfuvirtide, admin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::338666dd967a495a25b118c6624b67c5
https://doi.org/10.1177/135965350300800403
https://doi.org/10.1177/135965350300800403
Autor:
Margrit Carlson, Kevin T. Bui, Seema Mehta, Abbas Ardehali, David Ross, Bernard M. Kubak, Joseph P. Lynch, Matthew Leibowitz, Joanna Schaenman, T. Khuu, Rajan Saggar
Publikováno v:
Transplantation. 97(5)
BACKGROUND Extended spectrum β-lactamase (ESBL)-producing gram-negative bacilli are increasingly reported in patients with a variety of risk factors including prior cephalosporin and antibiotic usage, prolonged hospitalizations, existence of comorbi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64039e6e8c6a27b468b79e916edbf9b7
https://pubmed.ncbi.nlm.nih.gov/24162251
https://pubmed.ncbi.nlm.nih.gov/24162251
Autor:
Roy M, Gulick, Heather J, Ribaudo, Cecilia M, Shikuma, Christina, Lalama, Bruce R, Schackman, William A, Meyer, Edward P, Acosta, Jeffrey, Schouten, Kathleen E, Squires, Christopher D, Pilcher, Robert L, Murphy, Susan L, Koletar, Margrit, Carlson, Richard C, Reichman, Barbara, Bastow, Karin L, Klingman, Daniel R, Kuritzkes
Publikováno v:
JAMA. 296(7)
Three-drug antiretroviral regimens are standard of care for initial treatment of human immunodeficiency virus 1 (HIV-1) infection, but a 4-drug regimen could improve antiretroviral activity and be more effective than a 3-drug regimen.To compare the s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::af6c3131ece54b10c69e64bb585b6485
https://pubmed.ncbi.nlm.nih.gov/16905783
https://pubmed.ncbi.nlm.nih.gov/16905783
Autor:
Jacob P, Lalezari, Edwin, DeJesus, Donald W, Northfelt, Gary, Richmond, Peter, Wolfe, Richard, Haubrich, David, Henry, William, Powderly, Stephen, Becker, Melanie, Thompson, Fred, Valentine, David, Wright, Margrit, Carlson, Sharon, Riddler, Frances F, Haas, Ralph, DeMasi, Prokash R, Sista, Miklos, Salgo, John, Delehanty
Publikováno v:
Antiviral therapy. 8(4)
Enfuvirtide is a novel antiretroviral that blocks HIV-1 cell fusion and viral entry. This Phase II, controlled, open-label, randomized, multicentre dose-ranging trial explored the safety, antiviral activity and pharmacokinetics of enfuvirtide, admini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e40110131da9aa89683535a2dca90e10
https://pubmed.ncbi.nlm.nih.gov/14518696
https://pubmed.ncbi.nlm.nih.gov/14518696
Autor:
Margrit Carlson, Fred T. Valentine, Paul A. Volberding, Joel E. Gallant, Prakash R. Sista, Jacob Lalezari, J. Michael Kilby, Robert L. Murphy, Alex Dusek, Roberto C. Arduino, Calvin J. Cohen, Edwin DeJesus, Emily L. Nelson, Joseph J. Eron
Publikováno v:
AIDS (London, England). 17(5)
Objectives The primary objective was to determine the long-term safety of the subcutaneous self-administration of enfuvirtide. Secondary objectives included the determination of enfuvirtide pharmacokinetics and antiviral activity and the immunologica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::633f39c870a270202ba3a0e198fdbc9d
https://pubmed.ncbi.nlm.nih.gov/15090785
https://pubmed.ncbi.nlm.nih.gov/15090785